HAS opinions and decisions
La fiche de bon usage du médicament intitulée « Xolair (omalizumab) dans le traitement de l’asthme sévère», ci-jointe, est adoptée.
See also
HAS opinions and decisions
17/11/2017
eNq9WF1v2jAUfedXIKTtLQmBUsIWqDrWrkitxqBo016QSS5gauzUH0D36+cA5WMKYjW4D0TY1z6+8T0+9zrh1WJK8jPgAjNaL/husZAHGrEY01G90Hu8dYLCVSMXTtAM7QzT49xSqZCPCBKiXkit7gAQFe6vh/uvoOcDLzRy+ZANJhDJvXFKYuLeITF+QEk6Jh/OGI7zU5BjFtcLiZLL3nwoJNdeNOaMP4kERRB6655d66R/sdsfeinYf6AqAfwe0VEmKFAjzEhxDlQ2kYQR4y+Z0MOo75cqxWJQM1oCiw4IpngEbSTHbc5mOIY4eyVEBBgtMpzHXeAzAjJdJBPcm0RTYQSOJmjRgedWttPX2tqUC+kUHb/qX5SDmh8EQdEsxnxnq7LJo1/CS/rlYvWyWqt6QL0YIpxy3KGlol9zin750osjLxIi/WkWPgF3JyIxDF6bcYmIpbBh0dwnoKV1ODwfpUeMRULQyylbhTjSZuBaJuy9SPoGj1wLF9F79g8+VYR4b/S6t5YVSx6nqtVkisoD6nLbMd2IJqMSFocjaiaIcrHmIgZxPtg/jGYng7YaEByZap5WJQVC9jqtw5L3rmrxBQnocXty8RPTmM3F+WVoN+yWvE+WSpoJmvDY75dqwaVfqRifst+aYwdy1I3iLAFPCxQWp+hOiw7ZqYqjaZsN9Ura9+PrsqJiESJwoKbqG6qTJuprCWjtKNg7ZitDJui3m0dT/vxQwF+6y2YmNI7rm8ibSbeNfKDZeszxWb3ilj6iafJZM7KeEDXCVHwo3T6wWBG4u+6mzNVtbdXPyXMK5yjs6nbGrG6kT2oX6VdpL/s2E0Vq2Ju06id4oJ+SIe3O5s/BcQnwob7eiIgzQgYoneG7i63B2VgyICaIYJb+iRiHTduZAlXp6BNU8dgFpBRUL4JyYHbKebbojqVMxCfPm8/n7hgJR6Sb7g75CVnzassFcz4Yc+ItvDgTN+zzQ+fm7bm2d3u0UkyuiutVXrbk+mBVcL2N4KYSfqzcPPUKtZ6/vqplriG5ghNiscr21nJy6+b8aX57f7LmdntPg+0ts7zrIKmF1FaJrQbZ9fVJhYWOK73lWiC+D4f4wEe9g7wMvdUHxUYu9NKPiY3cX1cZ2Vg=
4kka23Vc2dpfk4FH